NeuroPace develops medical devices for brain disorder treatment. Its products include implantable neurostimulation systems, monitoring software, and support services for hospitals, neurologists, and people with drug-resistant epilepsy.
NeuroPace products and services overview:
Revenue: ~$76 million
Employees: 180
Headquarters: Mountain View, United States (USA)
NeuroPace is one of the...
NeuroPace is a company listed under the stock ticker NPCE (US).
View the org chart displaying its 28 main executives
Create your alert
to follow the executive moves at NeuroPace.
NeuroPace has 1,243 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Medtronic (Ireland).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.